title: Guerilla Warfare on the Pancreas? A Case of Acute Pancreatitis From a Supplement Known to Contain Anabolic-Androgenic Steroids.
abstract: Performance-enhancing drugs (PEDs) are commonly consumed in the United States with high prevalence of use in athlete populations and increased use by deployed service members. Many PEDs may contain anabolic-androgenic steroids (AAS), which are legally restricted and prohibited by many agencies due to their health risk.
  
  
  
  A unique case of acute pancreatitis associated with the use of the PED "Guerilla Warfare," a labeled AAS-containing supplement, is presented. The patient is a healthy 20-year-old male Marine who presented with multiple episodes of abdominal cramps each day for a month with decreased appetite and nonbilious vomiting. He reported a 6-week history of "Guerilla Warfare" PED use and review of systems identified fatigue and 12 lb reported weight loss. He presented with normal vital signs, tenderness in upper abdominal quadrants, elevated lipase (909 units/L), lactate dehydrogenase (193 units/L), and an enlarged pancreas with surrounding inflammation on computed tomography.
  
  
  
  This constitutes the first report of acute pancreatitis with the use of "Guerilla Warfare," and the second reported case with the use of any AAS-containing PED. Increased awareness of significant PED-associated adverse effects by both the civilian and military communities is needed to better characterize these risks moving forward.
authors.affiliation: Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.
authors.forename: Billy-Joe
authors.initials: BJ
authors.lastname: Liane
authors.affiliation: Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.
authors.forename: Charles
authors.initials: C
authors.lastname: Magee
mesh_terms: D019587:Dietary Supplements / Q000009:adverse effects; D006801:Humans; D008297:Male; D008889:Military Personnel; D010179:Pancreas / Q000187:drug effects* / Q000503:physiopathology; D010195:Pancreatitis / Q000209:etiology*; D058573:Performance-Enhancing Substances / Q000009:adverse effects / Q000627:therapeutic use; D045165:Testosterone Congeners / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D058573:Performance-Enhancing Substances; D045165:Testosterone Congeners